Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Aclaris Therapeutics, Inc. (ACRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Rock Springs Capital Management LP reports a 5.9% stake in Aclaris Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 4.9% stake in Aclaris Therapeutics, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/31/2023 |
SC 13G/A
| BlackRock Inc. reports a 7.6% stake in ACLARIS THERAPEUTICS, INC |
| 02/14/2022 |
SC 13G/A
| Rock Springs Capital Management LP reports a 6.3% stake in Aclaris Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Foresite Capital Fund III, L.P. reports a 7.6% stake in Aclaris Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| RENAISSANCE TECHNOLOGIES LLC reports a 2.7% stake in Aclaris Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 1.5% stake in Aclaris Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Rock Springs Capital Management LP reports a 6.2% stake in Aclaris Therapeutics, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Foresite Capital Fund III, L.P. reports a 13.7% stake in Aclaris Therapeutics, Inc. |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/22/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/09/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Rock Springs Capital Management LP reports a 3.9% stake in Aclaris Therapeutics, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
SC 13G/A
| Man Group plc reports a 3.1% stake in ACLARIS THERAPEUTICS, INC. |
| 02/07/2020 |
SC 13G/A
| FMR LLC reports a 0.5% stake in ACLARIS THERAPEUTICS INC |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 6.4% stake in ACLARIS THERAPEUTICS, INC |
| 02/04/2020 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 0% stake in ACLARIS THERAPEUTICS, INC. |
| 07/31/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/25/2019 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 9.7% stake in ACLARIS THERAPEUTICS, INC. |
| 12/10/2018 |
SC 13G/A
| FMR LLC reports a 5.5% stake in ACLARIS THERAPEUTICS INC |
|
|
|